Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Alleanza Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01896180
First received: July 8, 2013
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)